FNBT
HAE icon

FineMark National Bank & Trust’s Haemonetics HAE Stock Holding History

FineMark National Bank & Trust’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-20
Closed -$1K – 1419
2014
Q1 		$1K Hold
20
– – ﹤0.01% 1351
2013
Q4 		$1K Buy
+20
New +$823 ﹤0.01% 1413

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

FineMark National Bank & Trust's HAE Position: Q2 2014 in Review

FineMark National Bank & Trust sold out of Haemonetics (HAE) in Q2 2014, closing a stake of 20 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in HAE in Q4 2013 and held it in 2 quarters. The position peaked at $1K in Q1 2014. 175 funds tracked by Wall St. Rank hold HAE as of Q2 2014.

  • FineMark National Bank & Trust reported no remaining Haemonetics position as of Q2 2014 after selling out during the quarter.
  • FineMark National Bank & Trust sold 20 Haemonetics shares in Q2 2014, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in Haemonetics in Q4 2013 and held it in 2 quarters.
  • FineMark National Bank & Trust's Haemonetics position peaked at $1K in Q1 2014.
  • 175 funds tracked by Wall St. Rank held Haemonetics as of Q2 2014.

Based on FineMark National Bank & Trust's 13F filing for Q2 2014, filed 13 Aug 2014.